The FDA classed the recall Class II on Oct. 8 after flagging the North Carolina pharmacy's sterile practices in 2025. Lot numbers and NDC codes are listed.
Recap by typeshit. Full story at FOX 10 Phoenix.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A $90 Brooklyn vial held a filler used in lip balm plus 13 bacteria colonies, University of Iowa testers said. Two online orders shipped with no consultation.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
The health secretary told Fox News that Americans buy peptides anyway. The FDA sent the White House a proposal that could let pharmacies compound certain peptides, including BPC-157.
Weight loss may explain much of the knee benefit, but lab work hints at anti-inflammatory and cartilage effects worth a closer read.
Loading…